A lengthy Form 483 from the FDA listed a range of concerns that led to the agency’s surprise rejection of Jiangsu Hengrui ...

The Institute for Clinical and Economic Review (ICER) has issued an "access and affordability alert " for Verona Pharma’s ...

Biomarker testing can help shape more effective treatment regimens for lung cancer, helping patients avoid ineffective, ...

With several launches underway and partnerships driving sales growth, Sobi is gaining momentum in its quest to become a force ...

Despite a string of high-profile losses this year, at least three major drugmakers continue to fight back against the ...

Lilly is promoting Mounjaro despite facing supply constraints. Anat Ashkenazi, chief financial officer at Lilly, told ...

As Johnson & Johnson continues to attempt to Texas two-step its way around thousands of claims that its popular talcum powder ...

Lawmakers are mounting yet another attempt to change the rules on taxing drug ads. | Lawmakers are mounting yet another ...

To receive Vertex and CRISPR Therapeutics’ $2.2 million gene therapy Casgevy for sickle cell disease (SCD) and transfusion ...

While patent cliffs are looming for many of biopharma’s top-selling products, the industry has enormous capacity to respond ...

CordenPharma will invest 900 million euros ($981 million) over the next three years to bolster its ability to manufacture GLP ...

CAR-T specialist Legend Biotech has reportedly received a takeover bid and has tapped Centerview Partners as a financial ...